Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00334347 · ClinicalTrials.gov registry record · Phase 4
A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote DR
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT00334347: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT00334347 is a Phase 4 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 5 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00334347, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
To compare the time to response, response rates, remission rates, and side effects in Bipolar Disorder inpatients treated with Depakote ER or Depakote DR for acute mania or mixed mania.
Interventions
- DRUG Depakote ER
- DRUG Depakote DR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-09 |
| Phase | Phase 4 |
What the finished NCT00334347 record still lists
NCT00334347 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Depakote ER is the first listed.
NCT00334347 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00334347 about?
NCT00334347 is a clinical study titled "A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote DR". To compare the time to response, response rates, remission rates, and side effects in Bipolar Disorder inpatients treated with Depakote ER or Depakote DR for acute mania or mixed mania.
What is the current status of trial NCT00334347?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2006-06. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00334347?
The interventions under investigation include: Depakote ER (DRUG), Depakote DR (DRUG).
Who is sponsoring clinical trial NCT00334347?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00334347's enrollment target sits among peer trials
5 1989th of 2000 higher than 7 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia